Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

KYKYNB
5 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in KYNTRA BIO INC

Yes. Two Sigma holds 39,511 shares of KYNB (Kyntra Bio), worth $298,308, as of its Q2 2026 13F filing. It reduced the position by 10,000 shares (-20.2%) from Q1 2026. Two Sigma has held KYNB in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$298,308

Current Shares

39,511

Total Value Change

+$223,520

Total Shares Change

+25,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
39,511
-20.2%
$298,3080.0%$7.55
0
2026-Q1
Decreased
49,511
-19.1%
$335,6850.0%$6.78
0
2025-Q4
Increased
61,211
+52.2%
$537,4330.0%$8.78
34
2025-Q3
Increased
40,218
+185.0%
$492,6710.0%$12.25
39
2025-Q2
New
14,111
-
$74,7880.0%$5.30
29

Other major holders of KYNB: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used